DRUG — BRIGHT MINDS BIOSCIENCES INC.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1827401 ·
Last close
$20.51
Market Cap
$201.25M
52W High
$123.75
52W Low
$17.40
ADV30
256,149
Next earnings
2026-12-22

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -11,434,277 -2,398,255 310,336,533 307,828,515 2,543,873
Mar 2026 0 — -15,319,423 -10,459,627 312,365,111 309,691,863 3,832,687
Dec 2025 0 — -6,904,082 -7,565,318 90,879,853 89,047,867 1,599,304
Sep 2025 0 — -5,664,542 -4,085,603 84,421,539 82,908,589 2,376,616

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-26,361,063
Investing CF
—
Financing CF
$275,258,879
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.04
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-67,001,517
Inventory
—
Receivables
$1,101,944
ST Investments
—
EBIT TTM
$-39,322,324
Pretax Income TTM
$-24,508,803
Interest Exp TTM
—
Analysts
7

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Sep 2025 0 -13,937,584 -12,229,348 84,421,539 2,376,616 82,044,923 -8,691,619
Sep 2024 0 -2,822,767 -2,801,946 6,104,602 568,259 5,536,343 -1,850,186
Sep 2023 0 -7,386,414 -7,372,225 6,879,072 280,856 6,598,216 -7,024,265
Sep 2022 0 -14,975,092 -14,964,941 12,086,984 1,544,472 10,542,512 -13,587,116

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-5.89

Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)

max pain strike: $25.00 · spot: $20.76 · call volume: 32 · put volume: 21

Peers — same industry

TickerNameMarket CapLastDaily %
VOGX Vogenx, Inc. $200.25M $13.48 —
CYPH CYPHERPUNK TECHNOLOGIES INC. $205.29M $1.90 —
SIGA SIGA TECHNOLOGIES INC $196.16M $2.73 —
TRDA Entrada Therapeutics, Inc. $194.19M $4.96 —
ACIU AC Immune SA $209.79M $2.11 —

News headlines (Yahoo Finance, 1h cache)

FDA puts partial hold on Bright Minds’ Phase II seizure study
2026-11-03 12:41 · Yahoo
Bright Minds Biosciences Faces Partial FDA Clinical Hold on BMB-101 Phase 2 Epilepsy Study
2026-11-02 15:51 · Yahoo
Bright Minds stock plunges as FDA halts epilepsy trial
2026-11-02 15:02 · Yahoo
Bright Minds Biosciences' BMB-101 Phase 2 Trial Placed on FDA Partial Hold
2026-11-02 12:58 · Yahoo
3 Canadian Biotech Stocks With Up To 39% Net Margins
2026-10-22 16:14 · Yahoo
Bright Minds Biosciences And 2 More Canadian Biotech Stocks
2026-10-08 09:09 · Yahoo
Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference
2026-09-30 21:30 · Yahoo
What Makes Bright Minds Biosciences Inc. (DRUG) a Strong Momentum Stock: Buy Now?
2026-08-27 16:00 · Yahoo
Wall Street Analysts See a 97.01% Upside in Bright Minds Biosciences Inc. (DRUG): Can the Stock Really Move This High?
2026-08-26 13:55 · Yahoo
Wall Street Analysts See a 107.53% Upside in Bright Minds Biosciences Inc. (DRUG): Can the Stock Really Move This High?
2026-07-23 13:55 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.